Christopher Jones
Follow
Get notifications in MyBN when activity occurs.
Christopher Jones
Non-Executive Director / Perpetual
Christopher Jones has over 35 years of experience in the financial services industry as a chief investment officer and portfolio manager in the US.
Mr Jones was principal of CMVJ Capital, head of Blackrock's US Global Fundamental Equity and co-head of Global Active Equity. He also spent 32 years in a range of roles at Robert Fleming and Co and JP Morgan Asset Management, including as managing director and chief investment officer of growth and small cap equities for a period of 10 years.
Mr Jones was principal of CMVJ Capital, head of Blackrock's US Global Fundamental Equity and co-head of Global Active Equity. He also spent 32 years in a range of roles at Robert Fleming and Co and JP Morgan Asset Management, including as managing director and chief investment officer of growth and small cap equities for a period of 10 years.
Lists and Charts
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Tryptamine Therapeutics | $972k |
| 196th | | Pendal Group | $611.0m |
| 899th |  | IQ3CORP | $3.3m |
| 933rd | | Integrated Payment Technologies | $2.2m |
| 939th | | Australian Primary Hemp | $2.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Perpetual | 07 Aug 2024 |
| NEW ROLE: Non-Executive Director, Pendal Group | 03 Nov 2020 |
